Apple, Boeing, Exxon, McDonald’s, Visa and More Dow Earnings This Week
24/7 Wall St. has put together a preview of those Dow companies scheduled to report their quarterly results this week, including Apple, Boeing, Exxon, McDonald's and Visa.
All Work
Chris Lange
Alphabet, Amazon, Facebook and More Tech/Media Earnings Coming This Week
24/7 Wall St. has put together a preview of some of the larger tech companies that are about to report their quarterly results, including Alphabet, Amazon and Facebook.
AbbVie, Eli Lilly, Gilead, and More Biopharma Stocks Reporting Earnings This Week
Earnings season is in full swing, and we have put together a preview of some of the world’s largest players in the health care sector reporting this coming week.
Will the Credits Roll for AMC After This Reopening Delay?
Summer blockbusters may have to wait a little longer to hit theaters now that the world’s largest movie-theater chain announced that it would further delay its reopening.
Moderna’s Pain Is Arbutus’s Gain in COVID-19 Patent Ruling
Arbutus Biopharma stock has seen an incredible rise over the past few days after the firm won a patent dispute that could have implications for coronavirus vaccine frontrunner Moderna.
Goldman Sachs Sees Big Gains From 7 Biotech & Pharma Conviction Buy Stocks
Goldman Sachs has seven biopharma stocks on its Conviction Buy list, and these are not all coronavirus plays. The firm thinks these stocks could go on the offensive for the rest of the year.
The 5 Best Earnings Trends of the Week
While this earnings season may be written off due to the pandemic, the fundamentals still matter as a measure for how companies survived the crisis. 24/7 Wall St. has taken a look at a…
Are Record Intel Q2 Revenues Falling Short For Investors?
Chipmaker Intel reported second-quarter earnings per share of $1.23 and $19.73 billion in revenue, compared with consensus estimates that called for earnings of $1.11 per share and $18.55 billion in revenue.
This Analyst Sees Much More Upside for Chipotle After Earnings
Chipotle Mexican Grill has fared better during the pandemic than the rest of the industry. With shares just below all-time highs, it is understandable that some investors may be wary, but analysts only seem…
Milestone Pharma’s Next Big Move After FDA Nod
Milestone Pharmaceuticals shares more than doubled on Thursday after the company announced a key clinical and regulatory update.
Twitter’s Net Loss Can’t Hold Back Record Quarter
Twitter reported disappointing second-quarter financial results despite strong user growth on Thursday before the opening bell.
Why Tesla’s Q2 Is So Shocking
After markets closed Wednesday, electric vehicle maker Tesla reported $2.18 in earnings per share (EPS) and $6.04 billion in revenue, compared with consensus estimates that called for $0.03 in EPS and $5.23 billion in…
Microsoft Q4 Beat Doesn’t Move Investors
After markets closed Wednesday, Microsoft reported $1.46 in earnings per share (EPS) and $38.0 billion in revenue, compared with consensus estimates calling for $1.37 in EPS and $36.5 billion in revenue.
Best Buy Might Be Immune From the Amazon Threat
In the e-commerce era, when brick-and-mortar retailers by and large are failing, Best Buy is making a name for itself.
Pershing Square Tontine Finally Comes Public
Bill Ackman’s Pershing Square Tontine special purpose acquisition company entered the market on Tuesday above its original pricing.
Pfizer and BioNTech Set to Receive a Sweet Payoff for COVID-19 Vaccines
Pfizer and BioNTech S.E. aim to begin delivering 300 million doses of their vaccine for COVID-19 in 2021, but in the meantime, these companies will get a nice payoff.
United Airline’s Quarter: Less Crash More Burn
United Airlines reported a second-quarter net loss of $5.79 per share and $1.48 billion in revenue, compared with consensus estimates that called for a net loss of $9.02 in EPS and $1.32 billion in…
Snap Gets the Picture in Q2 But Investors Not Happy
Social media company Snap reported a second-quarter net loss of $0.09 per share and $454 million in revenue, compared with consensus estimates that called for a per-share loss of $0.09 and $438.09 million in…
Was Amazon Under Too Much Stress for Prime Day During the Pandemic?
Amazon.com is pushing back its much-lauded Prime Day due to the pandemic. Will this cause near-term pain for investors?
BioNTech Raises Over $400 Million to Boost COVID-19 Efforts
BioNTech is one of the leading companies in the race to a COVID-19 vaccine. With its shares up more than 160% year to date, it’s time to capitalize.